P3 Health Partners Announces First Quarter 2026 Results
P3 Health Partners reported Q1 2026 revenue of $386 million, up 4% year-over-year, with net income of $3.0 million compared to a $44.2 million loss in the prior year. Medical margin expanded significantly to $73.7 million ($231 PMPM), driven by contract restructuring and rate progression, while at-risk membership declined 10% to 106,000 due to intentional network rationalization.
Key figures
- Eps
- 0.37
- Revenue
- 386390000
- Guidance
- FY26 Adjusted EBITDA midpoint $40M (range $20M-$60M); Total Revenue $1.5B-$1.65B; Medical Margin $190M-$230M
- Revenue Yoy
- 4%
- Net income
- 3040000
- Gross profit
- 50366000
- Medical margin
- 73657000
- Adjusted ebitda
- 25759000
- At risk members
- 106000
- Operating income
- 8237000
- Medical margin pmpm
- 231
- Adjusted ebitda pmpm
- 81
- Total lives under management
- 135000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.